Functional interactions between protein kinase A (PKA) and epidermal growth factor receptor (EGF-R) signalling pathways have been suggested. Unlike the type II isoform of PKA (PKAII), the type I (PKAI) and/or its regulatory subunit RIa are generally overexpressed in cancer cells and are induced following transforming growth factor a (TGFa)/EGF-R-dependent transformation. Downregulation of RIa/PKAI inhibits TGFa expression and EGF-R-dependent signalling. We have previously shown that addition of EGF to quiescent human normal epithelial MCF-10A cells determines PKAI expression and cell membrane translocation before cells enter S phase, while PKAI inhibition prevents S phase entry. Constitutive overexpression of PKAI confers the ability to grow in serum free medium, bypassing EGF requirement. Here we demonstrate a direct interaction of PKAI, but not of PKAII, with the activated EGF-R, that occurs within 5 min following EGF treatment of MCF-10A cells. Moreover, induction of mitogen-activated protein kinase (MAPK) activity following EGF-R activation is mimicked by PKAI overexpression and inhibited by downregulators of PKAI. Finally, the PKAI ± EGF-R association occurs through the binding of RIa to the SH3 domain(s) of Grb2 adaptor protein, thus allowing the recruitment of the PKAI holoenzyme to the activated EGF-R. This is the ®rst demonstration of a direct interaction of PKAI with the activated EGF-R macromolecular signalling complex.
Introduction
Several studies have provided an indirect evidence for a functional involvement of PKA in the regulation of mitogenic signals transmitted through the EGF-R and/or p21 ras pathways (Tortora et al., 1989; Ciardiello et al., 1990a Ciardiello et al., , 1993 Wu et al., 1993; Cook and McCormick, 1993; Burgering et al., 1993) . It has been shown that, of the two PKA isoforms, PKAII and its regulatory subunit RIIb correlate with growth arrest and cell dierentiation, while PKAI and its regulatory subunit RIa are associated with cell proliferation and neoplastic transformation (Cho-Chung and Clair, 1993) . We have previously shown that ras-and TGFa-dependent transformation determines an early induction of RIa/PKAI expression and that, conversely, selective downregulation of PKAI expression or activity determines inhibition of TGFa and p21 ras expression and signalling (Tortora et al., 1989; Ciardiello et al., 1990a Ciardiello et al., , 1993 .
Human nontransformed breast epithelial MCF-10A cells possess approximately 250 000 EGF-R sites per cell (Ciardiello et al., 1990b) and depend on the presence of EGF or TGFa in the culture medium for optimal cell growth, since their withdrawal determines growth arrest in G 0 /G 1 (Tortora et al., 1994a) . Addition of complete medium containing EGF to quiescent cells induces RIa expression 6 ± 9 h before cells enter the S phase (Tortora et al., 1994a) . Selective downregulation of RIa/PKAI expression reduces or prevents S phase entry in MCF-10A as well as in other cell types, suggesting a role for PKAI in the G 1 to S transition (Tortora et al., 1994a) . Furthermore, retroviral vector-mediated RIa overexpression enables MCF-10A cells to grow in serum free medium, bypassing hormones and growth factors requirement (Tortora et al., 1994a) , thus conferring a phenotype similar to MCF-10A cells transformed by either the TGFa or the -ras gene (Ciardiello et al., 1990b) . Taken together these data suggest that RIa/PKAI mediate mitogenic signalling by various growth factors including TGFa or EGF.
In the present study we have used the MCF-10A cells as an in vitro cell model system to provide experimental evidence that PKAI participates to a macromolecular signalling complex with the ligandactivated EGF-R, and that this interaction is due to the binding of the RIa subunit to the SH3 domain(s) of Grb2 adaptor protein.
Results

RIa interacts with the ligand-activated EGF-R complex
To investigate whether RIa may directly participate to the EGF-R macromolecular signalling complex, lysates from quiescent and EGF-treated MCF-10A cells were immunoprecipitated with an anti-RIa antibody and the immune complexes were then Western blotted with an anti-EGF-R antibody (Figure 1a ). An association of RIa with the EGF-R was observed, reaching a peak within 5 min after EGF addition. A similar association was observed in a reciprocal experiment in which MCF-10A cell lysates were immunoprecipitated with an anti-EGF-R antibody and immunoblotted with the anti-RIa antibody (Figure 1b) . Analysis of the same cell extracts by Western blotting showed no increase of RIa expression up to 6 h, as previously reported (Figure 1c ) (Tortora et al., 1994a) , and no changes in the expression of EGF-R (Figure 1d ), while an induction of tyrosine phosphorylation of EGF-R was detected in EGF-treated cells (Figure 1e ). Moreover, a major 170 kDa band was observed in EGF-treated cells immunoprecipitated with the anti-RIa antibody and immunoblotted with an anti-phosphotyrosine antibody (Figure 1f ). When the same cell lysates immunoprecipitated with the anti-RIa antibody were Western blotted with an anti-erbB2 antibody, no speci®c interaction was oberved (data not shown). We also performed the reciprocal experiment, since anti-erbB2 immunoprecipitated cell lysates were Western blotted with an anti-RIa antibody, and no interaction between RIa and erbB2 was observed (data not shown). These data demonstrate that RIa interact with the activated EGR-R, but not with the closely related erbB2 receptor.
RIIb is unable to interact with the EGF-R To determine whether also RIIb associates with the EGF-R, MCF-10A cell extracts were immunoprecipitated with an anti-RIIb antibody and immunoblotted with an anti-EGR-R. No speci®c 170 kDa band was observed, suggesting that RIIb does not complex with EGF-R following ligand binding (Figure 2a ).
An active PKAI is associated with the activated EGR-R complex
To investigate whether the RIa subunit interacting with EGF-R is bound to the Ca catalytic subunit of PKA, MCF-10A cell lsyates were immunoprecipitated with the anti-EGF-R antibody and Western blotted with an anti-Ca antibody. As shown in Figure 2b , also Ca coprecipitates with EGF-R within 5 min following EGF treatment. In addition, a PKA phosphotransferase activity was detected in anti-EGF-R immunoprecipitates obtained from EGF-stimulated MCF-10A. In fact, as compared to the anti-RIa-immunoprecipitates, in quiescent cells there was little or no PKA activity coimmunoprecipitated with EGF-R, while after 5 min of EGF treatment the anti-EGF-R immunoprecipitates contained up to 34% of the total PKA activity ( Figure  2c ). These results demonstrate that a functional and speci®c isoform of PKA is associated with the activated EGF-R complex.
PKAI is involved in EGF-dependent MAP kinase activation
We next analysed the MAPK activity of quiescent and EGF-stimulated MCF-10A cells. We found that activity of total MAPK reaches a peak at 5 min after EGF treatment, returning at the initial levels within 60 min (Figure 3a) . Then we measured the MAPK activity of MCF-10A RIa cells, which overexpress RIa/ PKAI and have acquired the ability to grow in serumfree medium bypassing the requirement of EGF for cell proliferation (Tortora et al., 1994a) . The MAPK activity in absence of EGF was comparable to that of EGF-stimulated MCF-10A cells and did not increase following EGF addition, remaining stable up to 60 min ( Figure 3a ). To determine whether EGF-R and/or PKAI inhibitors could interfere with EGFinduced MAPK activity, the MCF-10A cells were pretreated for 24 h with either the anti-EGF-R blocking Mab528 antibody, as antisense oligonucleotide targeted against RIa (AS RI) (Cho-Chung and Clair, 1993; Tortora et al., 1994a) or the site-selective cAMP analog 8-Cl-cAMP which speci®cally downregulates PKAI (Ciardiello et al., 1990a; Tortora et al., 1990; Cho-Chung and Clair, 1993) . Mab528 determined more than 80% inhibition of the EGF-induced MAPK activity at 5 min of EGF treatment. The AS RIa and the 8-Cl-cAMP determined on inhibition of approximately 50% and 40%, respectively while a control RIa oligonucleotide in sense orientation had no signi®cant eect (Figure 3b ). When the AS RI and 8-Cl-cAMP were used in the MCF-10A RIa cells, an approximately 50% and 60% inhibition of MAPK activity, respectively was observed, whereas the sense oligonucleotide was not eective (Figure 3c ). Taken together these data demonstrate that PKAI plays a functional role in the EGF-dependent signaling to the MAPK.
RIa associates with Grb2 through the Grb2-SH3 domain(s)
To ascertain whether also in MCF-10A cells the ligandactivated EGF-R is associated with Grb2, lysates from quiescent and EGF-treated MCF-10A were immunoprecipitated with an anti-Grb2 antibody and the immune complexes were then Western blotted with an anti-EGF-R antibody (Figure 4a ). An association of Grb2 with the EGF-R was observed within 5 min after EGF addition. A similar association was observed in a reciprocal experiment in which MCF-10A cell lysates were immunoprecipiated with an anti-EGF-R antibody and immunoblotted with the anti-Grb2 antibody (Figure 4b ). We next investigated whether the interaction of PKAI with EGF-R may be mediated by the binding of RIa, which contains a sequence potentially capable to bind SH3 domains (SkaÊ lhegg et al., 1994; Schlessinger, 1994; Pawson, 1995) , to Grb2 adaptor molecule, which contains two SH3 domains (Rozakis-Adcock et al., 1993; Gale et al., 1993; Schlessinger, 1994; Pawson, 1995) . Cell lysates from quiescent and EGF-treated MCF-10A cells were immunoprecipitated with an anti-Grb2 antibody and immunoblotted with the anti-RIa antibody. RIa was associated with Grb2 independently from liganddependent EGF-R activation (Figure 5a ). We next tested the ability of RIa to bind in vitro the full length Grb2 or the Grb2 SH3-N, SH3-C and SH2 domains fused to GST. Following incubation of the various recombinant fusion proteins with MCF-10A cell lysates and immunoblotting with the anti-RIa antibody, we observed that GST ± Grb2, but not GST alone, complexed with RIa (Figure 5b ). Furthermore, both Grb2 ± SH3-N and -SH3-C domains were able to bind RIa in vitro, while the Grb-SH2 domain failed to do so, demonstrating that RIa interacts with Grb2 through its N-and C-terminal -SH3 domain(s) (Figure 5c ).
Discussion
Several studies have reported that PKAI expression and function is correlated to ras-and EGF-Rdependent mitogenic signalling. It has been recently suggested that PKAI may locate at the cell membrane. In fact, in human T lymphocytes PKAI is complexed with the T cell receptor and participates to T cell activation (Laxminarayana et al., 1993; SkaÊ lhegg et al., 1994) . Moreover, in EGF-stimulated MCF-10A cells, a cell membrane translocation of PKAI anticipates cell entry into S phase (Tortora et al., 1994a; Pepe et al., 1994) . These data have further supported a role for PKAI as an early signal in the mitogenic cascade. We have investigated whether participation to a cell membrane signalling complex occurs in MCF-10A human mammary epithelial cells in which growth is mainly sustained through an EGF-R-dependent mitogenic pathway. In this study we have demonstrated that in MCF-10A cells both RIa regulatory and Ca catalytic subunits coprecipitate with the activated EGF-R and that they are present in the macromolecular signalling complex as an activatable PKAI holoenzyme. On the other hand, PKAII has been found near dierent cytoplasmic structures mainly the Values are expressed as percent PKA activity relative to the total activity obtained in the anti-RIa immunoprecipitates at 5 min after stimulation with EGF (100 ng/ml) which was considered as 100% (SkaÊ lhegg et al., 1994) Golgi, but no evidence has been provided for a PKAII location at the cell membrane (Griths et al., 1990 ).
Here we have demonstrated that PKAII is unable to interact with the EGF-R. Therefore, only PKAI is able to complex with EGF-R following ligand activation. It has been proposed that erbB2 or an EGF-R/erbB2 heterodimer can mediate mitogenic signals following ligand binding to the EGF-R (Karunagaran et al., 1996) . In this report we show that while PKAI interacts speci®cally with EGF-R, no interaction occurs with erbB2. Several studies have correlated PKA activation and phosphorylation of raf-1 protein with the inhibition of EGR-R-and/or ras-dependent MAPK activation, but none has elucidated whether a speci®c PKA isoform is responsible for this eect (Wu et al., 1993; Cook and McCormick, 1993; Burgering et al., 1993) . Evidence has been provided that PKAII induction and overexpression determines inhibition of EGF-R-and rasdependent mitogenic signalling (Tortora et al., 1989 (Tortora et al., , 1994b Ciardiello et al., 1990a) . On the other hand, PKAI has been causally linked to positive regulation of signals from EGF-R and ras pathways (Tortora et al., 1989 (Tortora et al., , 1994a Ciardiello et al., 1990a Ciardiello et al., , 1993 . In this study we have demonstrated that overexpression of PKAI in MCF-10A RIa cells (Tortora et al., 1994a) determines a constitutive activation of MAPK, mimicking the eect of EGF addition to MCF-10A cells. Moreover, inhibitors of PKAI-mediated signalling, such as an anti-RIa AS oligonucleotide or 8-ClcAMP, signi®cantly reduce the level of MAPK activation. These data demonstrate that PKAI contributes to the propagation of EGF-R-activated intracellular signalling.
We have next tried to identify which protein could allow PKAI to interact with the EGF-R. Grb2 is an adaptor molecule, composed of one -SH2 and two -SH3 domains, coupling the EGF-R to the ras pathway (Rozakis-Adcock et al., 1993; Gale et al., 1993; Schlessinger, 1994; Pawson, 1995) . Since RIa contains a stretch of uncharged aminoacids and a N-terminal proline-rich sequence (SkaÊ lhegg et al., 1994) , which may potentially bind to SH3 domains, we investigated whether PKAI interaction with EGF-R may be mediated through RIa binding to Grb2. We found that RIa was associated with Grb2 independently from EGF-R activation, suggesting that RIa and Grb2 may complex before the ligand activates EGF-R and recruits Grb2 to autophosphorylated tyrosine residue(s). Moreover, we have performed in vitro binding assays using dierent GST fusion proteins containing either the -SH2 or the -C or N-terminal-SH3 domains of Grb2 and we have demonstrated that RIa binds both the Grb2-SH3 domains. Taken together these results suggest that the binding of RIa to the SH3 domain(s) of Grb2 may allow the recruitment of an activatable PKAI holoenzyme to the EGF-R site following ligand-dependent activation.
In this study we have disclosed a mechanism by which PKAI is involved in the EGF-R-dependent mitogenic signalling. To our knowledge this is the ®rst demonstration that a cross talk between a speci®c PKA isoform, PKAI, and a receptor tyrosine kinase, such as EGF-R, is due to a direct interaction. Since the association seems to occur via binding of the RIa subunit to the SH3 domain(s) of Grb2, allowing the recruitment of PKAI to the activated EGF-R, this may enable PKAI to interact with speci®c substrates involved in the mitogenic signalling.
As Grb2 connects growth signals from activated tyrosine kinase receptors with dierent intracellular transduction systems, such as ras and phospholypase Cg (Rozakis-Adcock et al., 1993; Gale et al., 1993; Schlessinger, 1994; Pawson, 1995) , it will be relevant to determine whether PKAI is involved only in a speci®c signalling pathway or participate to the integration of multiple growth factor-induced signals. Moreover, the identi®cation of speci®c PKAI substrates will be an important step to elucidate the mitogenic signalling cascade.
Materials and methods
Cell cutlures
MCF-A cells were grown in a 1 : 1 (v/v) Dulbecco's modi®ed Eagle Medium (DMEM) and Ham's F12 mixture, supplemented with 5% heat inactivated horse serum, 20 mM HEPES pH 7.4, 4 mM glutamine (ICN Biomedicals, Costa Mesa, CA), 0.5 mg/ml hydrocortisone (Sigma Chemicals Co., St. Louis, MO), 10 ng/ml EGF, 10 mg/ml insulin (Collaborative Research Products, Bedford, MA), 100 U/ml penicillin and 100 mg/ml streptomycin in a humidi®ed atmosphere of 95% air and 5% CO 2 at 378C as previously (Tortora et al., 1994a) . Treatment with a 21-mer phosphothioate oligodeoxynucleotide corresponding to the RIa subunit sequence (Sense) (10 mM) or a 21-mer phosphothioate oligodeoxynucleotide targeted against the same sequence in antisense orientation (AS RI) (10 mM) (Tortora et al., 1991) and 8-Cl-cAMP (10 mM) were performed as previously reported (Ciardiello et al., 1990a; Tortora et al., 1991 Tortora et al., , 1994a .
Immunoprecipitation and Western blot analysis
Total cell lysates from either serum-starved MCF-10A or from the same cells after replenishment of complete medium containing EGF (100 ng/ml) at dierent time points were immunoprecipitated with: an anity puri®ed polyclonal anti-RIa antibody, a polyclonal anti-RIIb antibody (both provived by Dr Cho-Chung, NCI, Bethesda) (Tortora et al., 1990) ; the 528 anti-EGF-R monoclonal antibody (provided by Dr Mendelsohn, MSKCC, New York) (Gill et al., 1984) ; the monoclonal anti-erbB2 and anti-Grb2 antibodies (Transduction Laboratories, Lexington, KY) following the method described (Ciardiello et al., 1990a; Lanfrancone et al., 1995) . For Western blot analysis, either immunoprecipitates or 50 mg total cell lysates were resolved by a 7.5% or a 12% SDSpolyacrylamide gel electrophoresis, probed with speci®c antibodies and revealed by horseradish-perodixase antiser- GST fusion proteins containing Grb2 (GST ± Grb2), the N-and Cterminal SH3 domains (GST ± SH3-N and GST ± SH3-C) or the SH2 domain (GST ± SH2) of Grb2 (Pelicci et al., 1992; Lanfrancone et al., 1995) were incubated with MCF-10A cell lysates and Western blotted with the anti-RIa antibody as above um (Bio-Rad Laboratories, Hercules, CA) followed by enhanced chemiluminescence reaction (Amersham International, England) as described previously (Tortora et al., 1994a; Lanfrancone et al., 1995) . The following speci®c antibodies were used: a monoclonal anti-EGF-R antibody (Transduction Laboratories); the polyclonal anti-RIa and anti-Ca antibodies (provided by Dr Cho-Chung) (Tortora et al., 1990) ; the monoclonal PY20 anti-P-Tyr, anti-erbB2 and anti-Grb2 antibodies (Transduction Laboratories).
PKA assay
For the analysis of the PKA phosphotransferase activity, protein extracts were incubated with the reaction mixture, spotted on phosphocellulose ®lters, dried and counted by liquid scintillation as described previously (Tortora et al., 1991) . PKA activity was determined in the cell lysates following immunoprecipitation with either anti-RIa or anti-EGF-R antibodies, as described previously (Laxminarayana et al., 1993; SkaÊ lhegg et al., 1994) .
Mitogen-activated protein kinase (MAPK) assay
For the analysis of total p42/44 MAPK activity (Wu et al., 1993; Cook and McCormick, 1993; Burgering et al., 1993 
Generation of recombinant fusion proteins and in vitro binding
Glutathione-S-Transferase (GST) and GST fusion proteins containing Grb2 (GST ± Grb2), the N-and C-terminal SH3 domains (GST ± SH3-N and GST ± SH3-C) or the SH2 domain (GST ± SH2) of Grb2 were expressed in bacteria (Pelicci et al., 1992; Lanfrancone et al., 1995) . Recombinant bacterial proteins were immobilized on Glutathione Sepharose 4B (Pharmacia LKB, Uppsala, Sweden) and incubated with MCF-10A cell lysates, then recovered proteins were extensively washed and analysed by Western blot analysis (Lanfrancone et al., 1995) for RIa immunoreactivity.
